vers la météo de la validation par utilisateur

Ingenuity208

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 48 - PMID ?

In chronic lymphocytic leukemia B cells , agonist monoclonal anti __SP__ __NODE__ protein antibody increases cleavage of __SP__ pro __NODE__ protein .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :
Analyse 0 
       +--------MOD_ATT:N-ADJ--------+                                +-------------OBJ:V-N-------------+                                              
       |         +---MOD_ATT:N-ADJ---+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+----------COMP:N-N(of)----------+             
       |         |          +MOD_ATT:+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                    +MOD_ATT:N-A+             
       |         |          |    +MOD+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+                    |    +MOD_AT+             
       |         |          |    |   |        |         |       |     |       |       |        |        |                    |    |      |             
 In chronic lymphocytic leukemia B cells , agonist monoclonal anti __SP__ __NODE__ protein antibody increases cleavage of __SP__ pro __NODE__ protein .
MOD_ATT:N-ADJ (cell,chronic)
MOD_ATT:N-ADJ (cell,lymphocytic)
MOD_ATT:N-N (cell,leukemia)
MOD_ATT:N-N (cell,B)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
COMP:N-N(of) (increase,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (__NODE__,pro)
Analyse 1 
       +--------MOD_ATT:N-ADJ--------+                                +-------------OBJ:V-N-------------+                                              
       |         +---MOD_ATT:N-ADJ---+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+--------------COMP:N-N(of)--------------+     
       |         |          +MOD_ATT:+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                    +---MOD_ATT:N-ADJ---+     
       |         |          |    +MOD+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+                    |           +MOD_ATT+     
       |         |          |    |   |        |         |       |     |       |       |        |        |                    |           |       |     
 In chronic lymphocytic leukemia B cells , agonist monoclonal anti __SP__ __NODE__ protein antibody increases cleavage of __SP__ pro __NODE__ protein .
MOD_ATT:N-ADJ (cell,chronic)
MOD_ATT:N-ADJ (cell,lymphocytic)
MOD_ATT:N-N (cell,leukemia)
MOD_ATT:N-N (cell,B)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
COMP:N-N(of) (increase,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 2 
       +--------MOD_ATT:N-ADJ--------+                                +-------------OBJ:V-N-------------+                                              
       |         +---MOD_ATT:N-ADJ---+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+--------------COMP:N-N(of)--------------+     
       |         |          +MOD_ATT:+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                    +---MOD_ATT:N-ADJ---+     
       |         |          |    +MOD+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+                    |    +--MOD_ATT:N-N-+     
       |         |          |    |   |        |         |       |     |       |       |        |        |                    |    |              |     
 In chronic lymphocytic leukemia B cells , agonist monoclonal anti __SP__ __NODE__ protein antibody increases cleavage of __SP__ pro __NODE__ protein .
MOD_ATT:N-ADJ (cell,chronic)
MOD_ATT:N-ADJ (cell,lymphocytic)
MOD_ATT:N-N (cell,leukemia)
MOD_ATT:N-N (cell,B)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
COMP:N-N(of) (increase,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,pro)
Analyse 3 
       +--------MOD_ATT:N-ADJ--------+                                +-------------OBJ:V-N-------------+                                              
       |         +---MOD_ATT:N-ADJ---+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+--------------COMP:N-N(of)--------------+     
       |         |          +MOD_ATT:+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+                         +--MOD_ATT:N-N-+     
       |         |          |    +MOD+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+                         |      +MOD_ATT+     
       |         |          |    |   |        |         |       |     |       |       |        |        |                         |      |       |     
 In chronic lymphocytic leukemia B cells , agonist monoclonal anti __SP__ __NODE__ protein antibody increases cleavage of __SP__ pro __NODE__ protein .
MOD_ATT:N-ADJ (cell,chronic)
MOD_ATT:N-ADJ (cell,lymphocytic)
MOD_ATT:N-N (cell,leukemia)
MOD_ATT:N-N (cell,B)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
COMP:N-N(of) (increase,protein)
MOD_ATT:N-N (protein,pro)
MOD_ATT:N-ADJ (protein,__NODE__)